Fidelity Investments’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$220M Buy
12,961,459
+5,041,406
+64% +$85.8M 0.01% 777
2025
Q1
$155M Buy
7,920,053
+4,602,759
+139% +$89.9M 0.01% 915
2024
Q4
$82.3M Sell
3,317,294
-894,223
-21% -$22.2M ﹤0.01% 1191
2024
Q3
$103M Sell
4,211,517
-196,178
-4% -$4.81M 0.01% 1087
2024
Q2
$103M Sell
4,407,695
-486,758
-10% -$11.4M 0.01% 1027
2024
Q1
$162M Sell
4,894,453
-1,285,869
-21% -$42.5M 0.01% 872
2023
Q4
$168M Sell
6,180,322
-317,509
-5% -$8.64M 0.01% 817
2023
Q3
$156M Sell
6,497,831
-639,878
-9% -$15.4M 0.01% 798
2023
Q2
$228M Buy
7,137,709
+1,050,156
+17% +$33.5M 0.02% 671
2023
Q1
$186M Buy
6,087,553
+1,121,564
+23% +$34.3M 0.02% 737
2022
Q4
$194M Buy
4,965,989
+381,854
+8% +$14.9M 0.02% 696
2022
Q3
$218M Sell
4,584,135
-215,964
-4% -$10.3M 0.02% 628
2022
Q2
$186M Sell
4,800,099
-614,997
-11% -$23.8M 0.02% 718
2022
Q1
$310M Buy
5,415,096
+1,493,793
+38% +$85.6M 0.02% 620
2021
Q4
$312M Sell
3,921,303
-2,863
-0.1% -$228K 0.02% 629
2021
Q3
$341M Sell
3,924,166
-3,761,094
-49% -$327M 0.03% 575
2021
Q2
$989M Buy
7,685,260
+1
+0% +$129 0.08% 231
2021
Q1
$615M Buy
7,685,259
+356,673
+5% +$28.5M 0.05% 361
2020
Q4
$598M Hold
7,328,586
0.05% 351
2020
Q3
$180M Buy
7,328,586
+356,674
+5% +$8.78M 0.02% 667
2020
Q2
$195M Hold
6,971,912
0.02% 622
2020
Q1
$125M Buy
+6,971,912
New +$125M 0.02% 678